Erste-Asset-Management-Gmbh

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
894
Total Value
7790662542
Accession Number
0001398344-25-009327
Form Type
13F-HR
Manager Name
Erste-Asset-Management-Gmbh
Data Enrichment
88% identified
785 identified109 unidentified

Holdings

894 positions • $7.8B total value
Manager:
Search and click to pin securities to the top
Page 19 of 45
HARTFORD INSURANCE GROUP, INC.
Shares:9.5K
Value:$1.2M
% of Portfolio:0.0% ($1.2M/$7.8B)
Arcutis Biotherapeutics, Inc.
Shares:73.1K
Value:$1.1M
% of Portfolio:0.0% ($1.1M/$7.8B)
ILLINOIS TOOL WORKS INC
Shares:4.7K
Value:$1.1M
% of Portfolio:0.0% ($1.1M/$7.8B)
Grab Holdings Ltd
Shares:250.0K
Value:$1.1M
% of Portfolio:0.0% ($1.1M/$7.8B)
Targa Resources Corp.
Shares:5.7K
Value:$1.1M
% of Portfolio:0.0% ($1.1M/$7.8B)
WEYERHAEUSER CO
Shares:38.0K
Value:$1.1M
% of Portfolio:0.0% ($1.1M/$7.8B)
BRIGHT HORIZONS FAMILY SOLUTIONS INC.
Shares:8.7K
Value:$1.1M
% of Portfolio:0.0% ($1.1M/$7.8B)
IMPERIAL OIL LTD
Shares:15.2K
Value:$1.1M
% of Portfolio:0.0% ($1.1M/$7.8B)
36118L106
Shares:10.0K
Value:$1.0M
% of Portfolio:0.0% ($1.0M/$7.8B)
AUTOLIV INC
Shares:11.6K
Value:$1.0M
% of Portfolio:0.0% ($1.0M/$7.8B)
Nu Holdings Ltd.
Shares:100.0K
Value:$1.0M
% of Portfolio:0.0% ($1.0M/$7.8B)
WOLFSPEED, INC.
Shares:398.1K
Value:$1.0M
% of Portfolio:0.0% ($1.0M/$7.8B)
Revolution Medicines, Inc.
Shares:27.4K
Value:$1.0M
% of Portfolio:0.0% ($1.0M/$7.8B)
Apellis Pharmaceuticals, Inc.
Shares:42.0K
Value:$1.0M
% of Portfolio:0.0% ($1.0M/$7.8B)
Hamilton Lane INC
Shares:6.8K
Value:$1.0M
% of Portfolio:0.0% ($1.0M/$7.8B)
CORCEPT THERAPEUTICS INC
Shares:18.3K
Value:$999.7K
% of Portfolio:0.0% ($999.7K/$7.8B)
Primerica, Inc.
Shares:3.5K
Value:$991.7K
% of Portfolio:0.0% ($991.7K/$7.8B)
AMICUS THERAPEUTICS, INC.
Shares:116.8K
Value:$985.0K
% of Portfolio:0.0% ($985.0K/$7.8B)
MICRON TECHNOLOGY INC
Shares:11.1K
Value:$981.4K
% of Portfolio:0.0% ($981.4K/$7.8B)
Immunovant, Inc.
Shares:52.5K
Value:$964.4K
% of Portfolio:0.0% ($964.4K/$7.8B)